BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30149396)

  • 21. Hyperprolactinemic Galactorrhea as a Side Effect of Aripiprazole: An Adolescent Case (Aripiprazole-Related Hyperprolactinemic Galactorrhea).
    Gunes S
    J Clin Psychopharmacol; 2018 Apr; 38(2):161-162. PubMed ID: 29360652
    [No Abstract]   [Full Text] [Related]  

  • 22. Aripiprazole-induced rabbit syndrome: a case report.
    Caykoylu A; Ekinci O; Kuloglu M; Deniz O
    J Psychopharmacol; 2010 Mar; 24(3):429-31. PubMed ID: 18957477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
    Selfani K; Soland VL; Chouinard S; Huot P
    Neurologist; 2017 Jan; 22(1):24-28. PubMed ID: 28009769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of aripiprazole for delirium in the elderly: a short review.
    Kirino E
    Psychogeriatrics; 2015 Mar; 15(1):75-84. PubMed ID: 25514894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covert Dyskinesia With Aripiprazole: A Case Report.
    Mahgoub Y; Hameed A; Francis A
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722028
    [No Abstract]   [Full Text] [Related]  

  • 26. Antipsychotic-associated psoriatic rash - a case report.
    Bujor CE; Vang T; Nielsen J; Schjerning O
    BMC Psychiatry; 2017 Jul; 17(1):242. PubMed ID: 28676105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Switching from antipsychotics to aripiprazole and risk of agitation].
    Chaumette B; Masson M; Barde M; Gay O; Gaillard R
    Encephale; 2018 Feb; 44(1):88-90. PubMed ID: 28552242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of aripiprazole in the treatment of obesity associated with the administration of neuroleptics of the second generation in patients with schizophrenia].
    Danilov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3):34-40. PubMed ID: 24781224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothermia induced by atypical neuroleptics.
    Schwaninger M; Weisbrod M; Schwab S; Schröder M; Hacke W
    Clin Neuropharmacol; 1998; 21(6):344-6. PubMed ID: 9844790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
    Schizophr Res; 2016 Jul; 174(1-3):120-125. PubMed ID: 27157800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obsessive-Compulsive Symptoms Associated With Aripiprazole Treatment in Bipolar Disorder: A Case Report.
    Gupta P; Gupta R; Balhara YP
    J Clin Psychopharmacol; 2017 Feb; 37(1):108-109. PubMed ID: 27930496
    [No Abstract]   [Full Text] [Related]  

  • 32. Aripiprazole and impulse-control disorders in high-risk patients.
    Mohan T; Dolan S; Mohan R; Dawson J
    Asian J Psychiatr; 2017 Jun; 27():67-68. PubMed ID: 28558898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary retention associated with aripiprazole: Report of a new case and review of the literature.
    Boyer MG; Kheloufi F; Denis J; Micallef J; Milh M
    Therapie; 2018; 73(3):287-289. PubMed ID: 29146041
    [No Abstract]   [Full Text] [Related]  

  • 34. Aripiprazole-induced transient myopia: A rare entity.
    Praveen Kumar KV; Chiranjeevi P; Alam MS
    Indian J Ophthalmol; 2018 Jan; 66(1):130-131. PubMed ID: 29283140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole and Impulse-Control Disorders: A Recent FDA Warning and a Case Report.
    Dhillon R; Bastiampillai T; Cao CZ; Eckert TG; Tibrewal P
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28102975
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
    J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial dopamine agonist-induced pathological gambling and impulse-control deficit on low-dose aripiprazole.
    Peterson E; Forlano R
    Australas Psychiatry; 2017 Dec; 25(6):614-616. PubMed ID: 28696131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Related to Aripiprazole Therapy.
    Taleb S; Zgueb Y; Ouali U; Jomli R; Kort Y; Nacef F
    J Clin Psychopharmacol; 2019; 39(6):691-693. PubMed ID: 31688404
    [No Abstract]   [Full Text] [Related]  

  • 39. Aripiprazole-induced hypersensitivity pneumonitis.
    Gunasekaran K; Murthi S; Jennings J; Lone N
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28487307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J; Garcia-Parajua P
    J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.